期刊
EXPERT REVIEW OF CLINICAL PHARMACOLOGY
卷 3, 期 6, 页码 797-805出版社
TAYLOR & FRANCIS LTD
DOI: 10.1586/ECP.10.59
关键词
acute lung injury; acute respiratory distress syndrome; alveolar epithelial cell; keratinocyte growth factor; keratinocyte growth factor-2
资金
- Shanghai Leading Academic Discipline Project [B115]
- Fudan University
- Shanghai Science & Technology Committee [08PJ1402900, 9540702600, 08DZ2293104]
Acute lung injury (ALI)/acute respiratory distress syndrome (ARDS) is an acute life-threatening form of hypoxemic respiratory failure with a high mortality rate, and there is still a great need for more effective therapies for such a severe and lethal disease. Dysfunction of endothelial and epithelial barriers is one of the most important mechanisms in hypoxia-associated ALI/ARDS. The acceleration of the epithelial repair process in the injured lung may provide an effective therapeutic target. KGF-2, a potent alveolar epithelial cell mitogen, plays an important role in organ morphogenesis and epithelial differentiation, and modulates a variety of mechanisms recognized to be important in alveolar repair and resolution in ALI/ARDS. Preclinical and clinical studies have suggested that KGF-2 may be the candidate of novel therapies for alveolar epithelial damage during ALI/ARDS.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据